Matthew Villani
Foot & Ankle Surgery · Tavares, FLNPI 1932450996
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.2%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. 43 manufacturers reported payments, led by Linvatec Corporation at 43.0% of the total. 2025 is the largest year on record at $38,222, more than ten times the $397 reported in 2019. Among foot & ankle surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 216 payments — averaging $485.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Linvatec Corporation$45K
- Arthrex$14K
- In2bones USA, LLC$13K
- DNE LLC$12K
- Medshape, Inc.$5K
- Theramicro, Inc.$4K
- plus $10K from 37 others
What the payments were for
- Royalty or licence$16,87216%
- Consulting fees$48,45046%
- Speaking & faculty fees$12,50012%
- Travel & lodging$13,87913%
- Food & beverage$6,3826%
- Education$6,1756%
- Other$5010%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Linvatec Corporation | 52 | $45,022 |
| Arthrex | 36 | $14,399 |
| In2bones USA, LLC | 15 | $13,202 |
| DNE LLC | 4 | $12,343 |
| Medshape, Inc. | 9 | $5,410 |
| Theramicro, Inc. | 2 | $4,000 |
| Reel Surgical, Inc. | 7 | $3,726 |
| Encore Medical, LP | 3 | $1,800 |
| Trilliant Surgical LLC. | 4 | $1,028 |
| Integra Lifesciences Corporation | 5 | $594 |
| Medline Industries LP | 3 | $413 |
| Sanara Medtech Inc. | 2 | $356 |
| Smith+Nephew | 12 | $318 |
| Stryker | 3 | $302 |
| Curonix LLC | 13 | $281 |
| Treace Medical Concepts, Inc. | 2 | $242 |
| Medtronic | 2 | $139 |
| Biocomposites Inc | 1 | $131 |
| Fusion Orthopedics USA, LLC | 1 | $125 |
| Biopro, Inc. | 1 | $111 |
| Amgen(2 entities) | 5 | $96 |
| Zimvie Inc. | 4 | $83 |
| Zimmer Biomet | 1 | $73 |
| Accufix Surgical Inc. | 1 | $72 |
| Bioventus LLC | 4 | $71 |
| Abbott | 2 | $38 |
| Johnson & Johnson(2 entities) | 2 | $36 |
| Organogenesis Inc. | 2 | $35 |
| Nevro Corp. | 1 | $29 |
| Pacira Pharmaceuticals Incorporated | 2 | $28 |
| Anika Therapeutics, Inc. | 1 | $27 |
| Orthofix Medical, Inc. | 2 | $26 |
| Kerecis Limited | 1 | $24 |
| Zyla Life Sciences, Inc. | 2 | $24 |
| Averitas Pharma Inc. | 1 | $22 |
| Theragen, Inc. | 1 | $22 |
| Endo USA, Inc. | 1 | $22 |
| Convatec Inc. | 1 | $21 |
| Next Science LLC | 1 | $19 |
| Axogen | 1 | $18 |
| Embody, Inc. | 1 | $16 |
| Cardiovascular Systems Inc. | 1 | $9 |
| Stimwave Technologies Incorporated | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BioBrace 23mm$15,423
- SEAL$12,343
- COLINK AFX$10,729
- ALLOAID$8,637
- COLINK 2$4,366
- ALLOGRAFT TISSUE$4,264
- CoLink$3,407
- QUANTUM$3,357
- Quantum Total Ankle$2,567
- DynaNail Helix, Washer, 15 mm$2,300
- Arsenal Ankle 10 Hole 1/3 Tubular Plate$1,003
- TriWay TTC Nail$1,000
- ACell$501
- DynaNail$400
- CellerateRx$356
- NEOSPAN SUPERELASTIC COMPRESSION STAPLE W/INSTRUMENTS, SIZE 10X10X10$146
- HOFFMANN$138
- FIXOS$138
- VARIAX$138
- ALLOGRAFT$138
How this compares
$104,759 in reported general payments places this provider in the 95th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 161 | $3,671 |
| Ciclopirox | 45 | $982 |
| Methylprednisolone | 115 | $828 |
| Terbinafine Hcl | 42 | $644 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 79 | $587 |
| Gabapentin | 55 | $498 |
| Doxycycline Hyclate | 42 | $314 |
| Meloxicam | 100 | $280 |
| Ibuprofen | 12 | $116 |
| Cephalexin | 20 | $74 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $50 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Tavares
- Joanne BalkaranTavares$47K
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$861K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$785K
- Mario CalaHialeah$541K
- Christopher ReevesLake Mary$424K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.